Year: 2023
Type: article
Abstract: On July 17, 2023, the Centers for Medicare & Medicaid Services (CMS) issued a memo proposing to permit Medicare coverage determinations for beta amyloid (Aβ)-targeted PET to be made by Medicare Administrative Contractors. As neuroradiologists, neurologists, and nuclear medicine physicians, we
DOI: 10.3174/ajnr.a8027
Authors: J. Ivanidze, A.S. Nordvig, A.R. Fajardo, A.J. Tsiouris, G.C.-Y. Chiang, J.R. Osborne
Institution: Weill Cornell Medicine
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W4387569345